Dr. Cathleen E Marshall

MD | Child Neurology


  3340 Providence Dr Ste A565, Anchorage
     Alaska, 99508-4691
  907-212-2321    907-212-8499 Maps & Directions
Dr. Cathleen E Marshall is a Anchorage, Alaska based neurologist who is specialized in Child Neurology. Her current practice location is 3340 Providence Dr Ste A565, Anchorage. Patients can reach her at 907-212-2321 or can fax her at 907-212-8499. Dr. Cathleen E Marshall is MD in Child Neurology and her NPI number (Unique professional ID assigned by NPPES) is 1083957070.
Dr. Cathleen E Marshall specializes in neurology with special skills in diagnosis and treatment of neurologic disorders of the neonatal period, infancy, early childhood, and adolescence.
Complete Profile:
Dr. Cathleen E Marshall speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Cathleen E Marshall
Specialization: Child Neurology
Gender:Female
Credentials: MD
Practice Address:3340 Providence Dr Ste A565, Anchorage,
Alaska, 99508-4691
Phone:907-212-2321
Fax:907-212-8499
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1083957070
NPI Enumeration Date: 28 Mar, 2013
NPI Last Update On: 04 Feb, 2021

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Cathleen E Marshall
Po Box 4105,
Portland, Oregon
Zip: 97208-4105
Phone Number: 866-907-1068
Fax Number: 425-917-9141
Patients can reach Dr. Cathleen E Marshall at 3340 Providence Dr Ste A565, Anchorage, Alaska or can call to book an appointment on 907-212-2321.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.